Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Oogkliniek Dr. K. Vanhoucke from Mol, company number BE0480005587, closed financial year 2025 with a result of € 265,645 after tax. For that financial year Oogkliniek Dr. K. Vanhoucke recorded a gross margin of € 719,741 and equity of € 2 million. Compared with financial year 2024, the result moved from € 136,691 to € 265,645. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 2 million
▼ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 265,645
▲ 94% vs 2024
Profit after tax over the fiscal year.
€ 41,793
▲ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 427,357 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 164,747
▼ 14% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 138,613
▼ 23% vs 2024
Of which on lease € 88,640.
Debts at end 2025
€ 738,458
▼ 11% vs 2024
€ 257,544 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 61,972
▼ 40% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 176,421
▼ 19% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 640,670 | € 764,147 | € 693,338 | € 719,741 | ▲ 4% |
| Profit after taxes | € 201,522 | € 228,382 | € 136,691 | € 265,645 | ▲ 94% |
| Equity | € 2,240,120 | € 2,203,571 | € 2,180,328 | € 2,018,615 | ▼ 7% |
| Total debts | € 1,510,453 | € 1,751,046 | € 1,469,702 | € 1,445,587 | ▼ 2% |
| Cash | € 8,971 | € 31,393 | € 40,930 | € 41,793 | ▲ 2% |
| Land & buildings | € 2,287,870 | € 2,207,131 | € 2,125,085 | € 2,045,196 | ▼ 4% |
| Retained profit | € 2,227,720 | € 2,191,171 | € 2,167,928 | € 2,006,215 | ▼ 7% |
| Dividend | € 0 | € 264,930 | € 159,935 | € 427,357 | ▲ 167% |
| Bank debt | € 1,144,381 | € 1,066,633 | € 831,213 | € 738,458 | ▼ 11% |
| Balance sheet total | € 3,750,572 | € 3,954,618 | € 3,650,030 | € 3,464,201 | ▼ 5% |
Key figures of Oogkliniek Dr. K. Vanhoucke, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Oogkliniek Dr. K. Vanhoucke?
What happened at Oogkliniek Dr. K. Vanhoucke in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 265,645 (▲ 94% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- Kristien Vanhoucke became a director. NBB
- New establishment in Mol. KBO
In short
From € 201,522 profit in 2022 to € 265,645 profit in 2025.
Paid € 415,150 in corporate taxes since 2022.
Best year ever: 2025, with € 265,645 profit.
Paid out € 852,223 in dividends to the owners in total.
A new publication or filing at Oogkliniek Dr. K. Vanhoucke? We notify you, reason included.
Follow Oogkliniek Dr. K. VanhouckeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Oogkliniek Dr. K. Vanhoucke is Kristien Vanhoucke. Kristien Vanhoucke is also behind PHARMASSISTANCE and Mediphar Invest.
Directors
According to the 2025 annual accounts
since 2003
Establishments
Establishment units
Physical locations of this company
Jakob Smitslaan 9 box a
2400 Mol
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0480.005.587
- VAT number
- BE 0480.005.587
- Registered office
- Jakob Smitslaan 9 bus a, 2400 Mol
- Names & denominations
- Oogkliniek Dr. K. Vanhoucke
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 April 2003
- Peppol
- Active · Active since 15 Jun 2025
- Activities · NACE
Activiteiten van medisch specialisten
Medische praktijken